卢美哌隆 T21069
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mL | 313368-91-1 | ¥198.00 | 询底价 |
50 mg | 313368-91-1 | ¥536.00 | 询底价 |
10 mg | 313368-91-1 | ¥233.00 | 询底价 |
100 mg | 313368-91-1 | ¥829.00 | 询底价 |
25 mg | 313368-91-1 | ¥368.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Lumateperone
描述: Lumateperone (ITI 722) 是一种 5HT2A 受体拮抗剂和多巴胺受体磷蛋白调节剂 (DPPM)。
体内活性: ITI-722 was evaluated in the rat quipazine head twitch model induced by quipazine which is a 5-HT2A agonist, ITI-722 have ED50 values of 0.12 mg/kg.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 3.93 mg/mL (10 mM)
关键字: presynaptic D2 receptor | dopamine D1 receptor | Serotonin Receptor | postsynaptic D2 receptor | Dopamine Receptor | 5-HT2A | schizophrenia | inhibit | Inhibitor | 5-HT Receptor | 5-hydroxytryptamine Receptor | ITI 007 | Lumateperone | ITI-722
相关产品: Agomelatine (L(+)-Tartaric acid) | Piboserod | SB 204741 | lumateperone Tosylate | Pergolide mesylate | Litoxetine HCl | BMY 7378 dihydrochloride | Alosetron hydrochloride | Ziprasidone hydrochloride monohydrate | Brexpiprazole S-oxide
相关库: Drug Repurposing Compound Library | Anti-Neurodegenerative Disease Compound Library | Neurotransmitter Receptor Compound Library | ReFRAME Related Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Inhibitor Library | GPCR Compound Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Approved Drug Library
卢美哌隆 T21069信息由TargetMol中国为您提供,如您想了解更多关于卢美哌隆 T21069报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途